Concepedia

Victor Yazbeck

VY

Statistics

Publications

11

Citations

336

H-Index

10

Active since

2006

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Virginia Commonwealth University

Institute for Molecular Medicine

University of Maryland, Baltimore

University of North Carolina at Chapel Hill

Victor Yazbeck is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and autophagy.

ORCID

Top concepts

Publications per year

2006–2020

11

Publications

11

Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma

Victor Yazbeck, Daniela Buglio, Georgios Georgakis et al. · Experimental Hematology · 2008 · 139 citations

, , +9

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

Victor Yazbeck, Danielle Shafer, Edward Brent Perkins et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 40 citations · Full text

, , +7

A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma

Beata Holkova, Victor Yazbeck, Maciej Kmieciak et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 25 citations · Full text

Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years

Christopher A. Yasenchak, Rodolfo Bordoni, Victor Yazbeck et al. · Blood · 2019 · 23 citations

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Beata Holkova, Maciej Kmieciak, Prithviraj Bose et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 22 citations · Full text

, , +18

1–5 of 11